Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) said that a second subject has been registered in the pilot research of its Neuro-Spinal Scaffold which is used for the treatment of traumatic spinal cord injury. The study will be conducted at the Carolinas Medical Center in Charlotte, NC. It will evaluate the…